<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/23D04EC2-3A05-4711-B472-F29894825709"><gtr:id>23D04EC2-3A05-4711-B472-F29894825709</gtr:id><gtr:name>Institute of Zoology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BE5027A2-9A29-4322-AB89-41E0AF3BC9FF"><gtr:id>BE5027A2-9A29-4322-AB89-41E0AF3BC9FF</gtr:id><gtr:name>MedImmune</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F20FFE5B-3DA6-4629-894F-4CE13B49B4E4"><gtr:id>F20FFE5B-3DA6-4629-894F-4CE13B49B4E4</gtr:id><gtr:name>Vanderbilt University</gtr:name><gtr:address><gtr:line1>Vanderbilt University</gtr:line1><gtr:line2>2201 West End Avenue</gtr:line2><gtr:line4>Nashville</gtr:line4><gtr:line5>Tennessee</gtr:line5><gtr:postCode>TN 37235</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/23D04EC2-3A05-4711-B472-F29894825709"><gtr:id>23D04EC2-3A05-4711-B472-F29894825709</gtr:id><gtr:name>Institute of Zoology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BE5027A2-9A29-4322-AB89-41E0AF3BC9FF"><gtr:id>BE5027A2-9A29-4322-AB89-41E0AF3BC9FF</gtr:id><gtr:name>MedImmune</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F20FFE5B-3DA6-4629-894F-4CE13B49B4E4"><gtr:id>F20FFE5B-3DA6-4629-894F-4CE13B49B4E4</gtr:id><gtr:name>Vanderbilt University</gtr:name><gtr:address><gtr:line1>Vanderbilt University</gtr:line1><gtr:line2>2201 West End Avenue</gtr:line2><gtr:line4>Nashville</gtr:line4><gtr:line5>Tennessee</gtr:line5><gtr:postCode>TN 37235</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3C96DA84-6B39-449A-983F-AFBA3C0063C3"><gtr:id>3C96DA84-6B39-449A-983F-AFBA3C0063C3</gtr:id><gtr:firstName>Leo</gtr:firstName><gtr:surname>James</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105181010"><gtr:id>9ADFD187-3BA5-4954-93FE-8F23F8A79000</gtr:id><gtr:title>Intracellular immunity</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105181010</gtr:grantReference><gtr:abstractText>TRIM proteins play a crucial role in human health. Antiviral TRIMs protect against viral infection, whilst disruption of other TRIM proteins can increase susceptibility to disease, cause congenital defects or mediate autoimmune disease.
We are determining the mechanisms by which TRIM proteins work using multidisciplinary techniques that examine function on both the molecular and cellular level. Understanding TRIM function should help in the design of antivirals and in treating TRIM-mediated disease.</gtr:abstractText><gtr:technicalSummary>The human TRIM family comprise 70 members and are implicated in diverse cellular processes including cell proliferation, differentiation, development, oncogenesis and apoptosis. Our research program is designed to determine the mechanisms of function and dysfunction of two groups of TRIM proteins that are particularly crucial to human health ? the antiviral and disease-associated TRIMs. 
Antiviral TRIMs operate intracellularly to restrict viral replication. The mechanism by which these TRIMs target virus and prevent replication is not known. To understand these mechanisms and how viral specificity is encoded, we are determining the detailed three-dimensional interactions that occur between the multiple domains of TRIM proteins, viral proteins and the host cell machinery. In particular we are interested in why human TRIM5alpha, which in primates limits SIV replication, is defective against HIV. 
Disease-associated TRIMs are those in which disruption of function has been shown to mediate disease. Dysfunction of these TRIM proteins can increase susceptibility to disease (e.g. TRIM20/pyrin), cause congenital defects (e.g. TRIM18/mid1) or mediate autoimmunity (e.g. TRIM21/Ro52). We are using a combined molecular and cellular approach to determine both the mechanisms of function of these TRIMs and their path</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-08-15</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>9008205</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Vanderbilt University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Co-factor interactions with HIV hexameters</gtr:description><gtr:id>6EA47556-AE6E-406A-B675-5343909641A0</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56cf211b961fa2.43487058-1</gtr:outcomeId><gtr:partnerContribution>Text here</gtr:partnerContribution><gtr:piContribution>Text here</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oslo</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:description>Antibody mutagenesis and effect on TRIM21</gtr:description><gtr:id>76921A52-62AB-442A-9B91-3F4221EE2154</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56cf217f3c0c25.41600217-1</gtr:outcomeId><gtr:partnerContribution>Add</gtr:partnerContribution><gtr:piContribution>Add</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MedImmune</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Antibody immunity in neurodegenerative disease</gtr:description><gtr:id>B4C821A0-77AA-4CBA-BD7D-7CA7226BE988</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56cf224fb4e878.70451007-1</gtr:outcomeId><gtr:partnerContribution>See under Further Funding</gtr:partnerContribution><gtr:piContribution>Knowledge, materials</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>HIV post-entry biology</gtr:description><gtr:id>D257A58A-A2E8-47A9-9B38-85B59F2C4D31</gtr:id><gtr:impact>Publications (see previous list)</gtr:impact><gtr:outcomeId>tiyYDnBhUES-1</gtr:outcomeId><gtr:partnerContribution>Prof Greg Towers and I have published a number of joint papers (see published work).</gtr:partnerContribution><gtr:piContribution>Prof Greg Towers and I have published a number of joint papers (see published work).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC - University of Glasgow Centre for Virus Research</gtr:department><gtr:description>FIV post entry biology</gtr:description><gtr:id>E40C31F6-678E-42DE-AB44-15ED801B55FA</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>KYuakcf9Zqq-1</gtr:outcomeId><gtr:partnerContribution>Prof. Brian Willett and I have published several papers together.</gtr:partnerContribution><gtr:piContribution>Prof. Brian Willett and I have published several papers together.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Zurich</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Single particle microscopy</gtr:description><gtr:id>937DE9F6-FCF7-44E2-BBED-9849D1D10AD5</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56cf21c2b1f219.38442854-1</gtr:outcomeId><gtr:partnerContribution>Add</gtr:partnerContribution><gtr:piContribution>Add</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cambridge Big Biology Day 2015</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>ACE81A17-63B1-4333-ABD2-980AE37E1636</gtr:id><gtr:impact>TBC</gtr:impact><gtr:outcomeId>56cf3bb7af57d7.21102323</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.rsb.org.uk/get-involved/biologyweek</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LMB Open Day 2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>023329AE-6317-4071-A61E-784B5E579B01</gtr:id><gtr:impact>Something</gtr:impact><gtr:outcomeId>5460b08d8d6de5.64902302</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC2 Television Documentary</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>81EA86AD-515B-46CD-802F-A6647E0ACFBB</gtr:id><gtr:impact>I acted as scientific consultant for the programme &amp;quot;Secret life of the Cell&amp;quot; shown on BBC2 21st October at 8pm. Also one of my graduate students appeared many times during the programme giving on-camera interviews and narration.

Again, quite a bit of public response. Including requests for visits to sixth-form pupils (eg The Leys School Russell Group).</gtr:impact><gtr:outcomeId>DYH3ZHc4DEN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Year 11 Work experience placement with W McEwan</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>03C4EE8B-2A0C-4703-883C-027941D5CB26</gtr:id><gtr:impact>Work experience student reported that the whole experience definitely reinforced and made clearer her love for science, and confirmed her interest in taking Biology and Chemistry at A-Level</gtr:impact><gtr:outcomeId>56cf3f70d0b8d9.65120404</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Summer Exhibition 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>66AA175E-6CE3-4C4B-9E44-AE8DB11FFE73</gtr:id><gtr:impact>Over 12,500 visitors attended the exhibition. Feedback was overwhelmingly positive This is one of the very best exhibits here and the people were fantastic&amp;quot;

TBC</gtr:impact><gtr:outcomeId>PQ1mrZFjrKJ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Primary School Visit by W McEwan 2015</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E5496D5F-CF7E-4B4D-BEB9-D0B9BAC85A75</gtr:id><gtr:impact>- year 4 and 5 whole afternoon session with several activities with WM and school's teaching staff 
- a brief introduction to viruses and immunity
- group work where students saw their own cheek cells down the microscope
- accurate pipetting competition (with prizes for fastest and most accurate pipettors)
- using virus wars nets to make own 3D viruses from paper
- diagnosing virus infection in 'stool' samples (actually harmless kitchen materials)
- assembly to whole school about viruses and immunity</gtr:impact><gtr:outcomeId>56cf3e033dd506.35778864</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Primary School Visit by W McEwan 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>249D6004-88B6-4837-96A6-6516117798C5</gtr:id><gtr:impact>- year 4 and 5 whole afternoon session with several activities with WM and school's teaching staff 
- a brief introduction to viruses and immunity
- group work where students saw their own cheek cells down the microscope
- accurate pipetting competition (with prizes for fastest and most accurate pipettors)
- using virus wars nets to make own 3D viruses from paper
- diagnosing virus infection in 'stool' samples (actually harmless kitchen materials)
- assembly to whole school about viruses and immunity</gtr:impact><gtr:outcomeId>56cf3cca6155b7.73815328</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A602D113-AB8B-4001-AC3C-24DA1C1A9B7A</gtr:id><gtr:impact>I gave live interviews to the Today programme on Radio 4, Radio 5 live, BBC Worldservice and BBC Cambridgeshire.

Diverse interest from the public</gtr:impact><gtr:outcomeId>TY8tzXbaaNk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Television interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AC7DE718-DCC5-4D20-842A-5569FEC29006</gtr:id><gtr:impact>I gave television interviews for BBC, ITV, Channel 4 and Sky News. These were shown on breakfast TV and in prime-time news broadcasts.

I received many email requests from different members of the public for follow-up talks, questions etc.</gtr:impact><gtr:outcomeId>TECxnZ3aJC3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Secondary School Visit by W McEwan 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9EF7E209-6E1D-472E-951A-116C52E82CD9</gtr:id><gtr:impact>Session comprised:

-1 hour session with sixth form students
- 1 hour session with GCSE students
- display of the replica viruses from virus wars.
- videos of our 'Day in the life of a scientist'
- talk by WM about immunity to viruses
- question and answer session</gtr:impact><gtr:outcomeId>56cf3c7315a421.65770265</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5A86E28F-65D8-475E-8918-C9734813C35A</gtr:id><gtr:impact>talk sparked questions and discussion afterwards

After the event we had several school children email and subsequently visit the lab.</gtr:impact><gtr:outcomeId>546244f7385ab2.38423448</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>104000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Gates Cambridge Scholarship</gtr:department><gtr:description>Gates Studentship - Schweitzer</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Higher Education Funding Council for England (HEFCE)</gtr:fundingOrg><gtr:id>B7C90EC5-9FD3-4D27-87BA-DFF9DBC4E93D</gtr:id><gtr:outcomeId>5460a726555ee5.08364226</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>29483</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EMBO Long term Fellowship (Labzin)</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:fundingRef>EMBO ALTF 1487-2015</gtr:fundingRef><gtr:id>E69AB9C1-8774-4684-9E70-6405B56B16E0</gtr:id><gtr:outcomeId>58b987ea5d7525.59824894</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>78000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Magdalene College</gtr:department><gtr:description>Junior Research Fellowship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>CBF8553D-019D-4A39-B7B2-D1A9333CEDE2</gtr:id><gtr:outcomeId>58b99408549441.87790782</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1576088</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Investigator Award</gtr:description><gtr:end>2021-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>200594/Z/16/Z</gtr:fundingRef><gtr:id>F6FBA282-7610-45FF-9B87-704B9341EE5D</gtr:id><gtr:outcomeId>58b98759b49f68.39127524</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Darwin Trust of Edinburgh</gtr:department><gtr:description>Darwin Trust Studentship - Bichel</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>British Society for the History of Science (BSHS)</gtr:fundingOrg><gtr:id>0ADDD1FF-98EB-4E3D-8DF8-6F3F233EB2A7</gtr:id><gtr:outcomeId>5460a59497a536.04714588</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1124340</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC Starting Investigator Award</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>281627-IAI</gtr:fundingRef><gtr:id>6F1E5DEE-A80C-4702-9C47-5ECEE4348D93</gtr:id><gtr:outcomeId>WqUVVQhqqBb</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>187402</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>NHMRC CJ Martin Biomedical Training Fellowship (Dickson)</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:fundingRef>APP1110116</gtr:fundingRef><gtr:id>BCBC418B-8FC6-4363-885C-47A32BA88E92</gtr:id><gtr:outcomeId>56cf2a6639a532.27197922</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>249384</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>CJ Martin Fellowship (Labzin)</gtr:description><gtr:end>2021-05-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:id>D82195C7-2AE5-4577-A51E-C8AFE39AC904</gtr:id><gtr:outcomeId>58b993403c34a8.17562281</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>63000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>FCI Studentship - Hauler</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Chemical Industry Fund (Fonds der Chemischen Industrie)</gtr:fundingOrg><gtr:id>F18550C8-AB9B-4A35-9954-E131C2670B62</gtr:id><gtr:outcomeId>5460a494338d43.29650978</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>66333</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical School Studentship - J Tam</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>09DEE107-44EF-4AE2-B70A-F65204138626</gtr:id><gtr:outcomeId>RWYNjWJwvco</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65766</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship (Zeng)</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:id>53BAA5D7-2336-43A8-9CDD-BD090EAFB227</gtr:id><gtr:outcomeId>58b99468ef7e95.49947541</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Research and Development AstraZeneca</gtr:department><gtr:description>AstraZeneca/LMB Blue Skies Initiative</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>1C4B33B2-425A-48FB-83F6-AEE02BCACB1E</gtr:id><gtr:outcomeId>56cf240243df63.21222869</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>72252</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Junior Research Fellowship, Emmanuel College, Cambridge (Price)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>C5E51F1D-BB24-4083-98B7-5740F028BDA7</gtr:id><gtr:outcomeId>56cf29406e6f17.38425800</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>323244</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>NHMRC Biomedical Training Fellowship (Jacques)</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:fundingRef>APP1036521</gtr:fundingRef><gtr:id>50F90720-919C-4987-A3E1-5C06139B40BE</gtr:id><gtr:outcomeId>5460a6a3118e18.54510045</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Intracellular Immunity; use of TRIM21 and antibodies in treating viral infections</gtr:description><gtr:grantRef>MC_U105181010</gtr:grantRef><gtr:id>830EBA42-A988-4D04-927A-8A58D74E6714</gtr:id><gtr:impact>various</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>ogHBFJYYs3D</gtr:outcomeId><gtr:patentId>WO2012010855</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Patent WO/2012/010855</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Meeting with David Willetts - Minister of State for Universities and Science Department for Business, Innovation and Skills</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C99892CB-3F07-40D9-B30F-9993D90CE23D</gtr:id><gtr:outcomeId>f4193uaPPvG</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>pdb coordinates</gtr:description><gtr:id>9617A5EA-313B-4F2A-B021-698760D35189</gtr:id><gtr:impact>advance of the field</gtr:impact><gtr:outcomeId>83A06DE28D4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>crystallographic structure</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>230EE1C9-8112-4156-B43C-7EB1ACF12C9F</gtr:id><gtr:title>TRIM21 Promotes cGAS and RIG-I Sensing of Viral Genomes during Infection by Antibody-Opsonized Virus.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e12615f8d2a81b6cd87d0ed97813bb3a"><gtr:id>e12615f8d2a81b6cd87d0ed97813bb3a</gtr:id><gtr:otherNames>Watkinson RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56cf1602922569.48669806</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14422224-6A39-475C-958B-D72EE9857B6A</gtr:id><gtr:title>Cyclophilin A levels dictate infection efficiency of human immunodeficiency virus type 1 capsid escape mutants A92E and G94D.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5535e5b095530624beba13046aa94cd9"><gtr:id>5535e5b095530624beba13046aa94cd9</gtr:id><gtr:otherNames>Ylinen LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5D163F1816B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97110C32-821D-42F2-8647-BB96FC18C833</gtr:id><gtr:title>Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a6beffb1b3dfaecfccd9f955cc3b231"><gtr:id>2a6beffb1b3dfaecfccd9f955cc3b231</gtr:id><gtr:otherNames>Price AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56cf148d7990a0.96807010</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>600E3346-2CA3-4AF9-B44A-05F9A6C29505</gtr:id><gtr:title>Regulation of virus neutralization and the persistent fraction by TRIM21.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5127c337c4d35c97966a996e685b8462"><gtr:id>5127c337c4d35c97966a996e685b8462</gtr:id><gtr:otherNames>McEwan WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_14669_29_22647693</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18F2F909-DB16-408F-AEA3-788EB7BFE7B2</gtr:id><gtr:title>HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4db6155b7727bc65964379121650f2f6"><gtr:id>4db6155b7727bc65964379121650f2f6</gtr:id><gtr:otherNames>Zhou J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56cf148d45f7b9.47920396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C33FE6B-4C8A-4F3D-BAEE-185B276474A9</gtr:id><gtr:title>Active site remodeling switches HIV specificity of antiretroviral TRIMCyp.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a6beffb1b3dfaecfccd9f955cc3b231"><gtr:id>2a6beffb1b3dfaecfccd9f955cc3b231</gtr:id><gtr:otherNames>Price AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>7025F08895F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B2CD680-94B7-4A07-823A-02861BB56C19</gtr:id><gtr:title>Characterization of host proteins interacting with the lymphocytic choriomeningitis virus L protein.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28ba6f597b876f543f6178430d8302ac"><gtr:id>28ba6f597b876f543f6178430d8302ac</gtr:id><gtr:otherNames>Khamina K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5a99801b89cca7.56509286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5252AF02-5597-46DB-B562-C12346F1F843</gtr:id><gtr:title>Simultaneous neutralization and innate immune detection of a replicating virus by TRIM21.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e12615f8d2a81b6cd87d0ed97813bb3a"><gtr:id>e12615f8d2a81b6cd87d0ed97813bb3a</gtr:id><gtr:otherNames>Watkinson RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_14669_29_23596308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>400609EA-D0B9-423E-8EFE-3926C9CA1926</gtr:id><gtr:title>Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67ee1bfb5a1155a3bcda94cdd6481620"><gtr:id>67ee1bfb5a1155a3bcda94cdd6481620</gtr:id><gtr:otherNames>Bidgood SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5460a1531b1ff4.99803926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>102E6ECC-6A5C-4B8C-B10E-1813BC3D7FC5</gtr:id><gtr:title>Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5127c337c4d35c97966a996e685b8462"><gtr:id>5127c337c4d35c97966a996e685b8462</gtr:id><gtr:otherNames>McEwan WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58c922adad0036.19258916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFA19897-ACB7-47C3-9016-B219CC88EBC9</gtr:id><gtr:title>Acetylation regulates cyclophilin A catalysis, immunosuppression and HIV isomerization.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3aff5491201d9c3ac1211563d4f3218e"><gtr:id>3aff5491201d9c3ac1211563d4f3218e</gtr:id><gtr:otherNames>Lammers M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>CvaTJdDVDSx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73C09807-D91E-4713-A60B-F5B437714F63</gtr:id><gtr:title>CPSF6 defines a conserved capsid interface that modulates HIV-1 replication.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a6beffb1b3dfaecfccd9f955cc3b231"><gtr:id>2a6beffb1b3dfaecfccd9f955cc3b231</gtr:id><gtr:otherNames>Price AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_14669_29_22956906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09DE9B9F-B6E1-4FE1-B6F5-0F670386FA0C</gtr:id><gtr:title>TRIM21-dependent intracellular antibody neutralization of virus infection.</gtr:title><gtr:parentPublicationTitle>Progress in molecular biology and translational science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5127c337c4d35c97966a996e685b8462"><gtr:id>5127c337c4d35c97966a996e685b8462</gtr:id><gtr:otherNames>McEwan WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1877-1173</gtr:issn><gtr:outcomeId>56cf1602bc3500.47814138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73A322EC-391F-4E86-9EBA-6008BDF89E29</gtr:id><gtr:title>HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b80e4206e65c27027c5eb4c5816ed08"><gtr:id>2b80e4206e65c27027c5eb4c5816ed08</gtr:id><gtr:otherNames>Schaller T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_14669_29_22174692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96353076-9B64-4CAA-8D2E-DC1576C3EFDB</gtr:id><gtr:title>Restriction of the felid lentiviruses by a synthetic feline TRIM5-CypA fusion.</gtr:title><gtr:parentPublicationTitle>Veterinary immunology and immunopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f25e8a22839c8eaf9492900e3ab52a36"><gtr:id>f25e8a22839c8eaf9492900e3ab52a36</gtr:id><gtr:otherNames>Dietrich I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0165-2427</gtr:issn><gtr:outcomeId>aqdJ87bJafk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D99F008-A465-4FB2-8D0D-A07A0B10A6DA</gtr:id><gtr:title>HIV-1 evades innate immune recognition through specific cofactor recruitment.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34c1e8ababaaac31f24b1fb218be5bbb"><gtr:id>34c1e8ababaaac31f24b1fb218be5bbb</gtr:id><gtr:otherNames>Rasaiyaah J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5460a1524bbd18.60139218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBF79F74-855A-4442-A70E-7C22F5BB2CE1</gtr:id><gtr:title>Conformational adaptation of Asian macaque TRIMCyp directs lineage specific antiviral activity.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5535e5b095530624beba13046aa94cd9"><gtr:id>5535e5b095530624beba13046aa94cd9</gtr:id><gtr:otherNames>Ylinen LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>smzH89GodPj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C01E2775-3C35-4F53-AFAC-F95C8D06D8FD</gtr:id><gtr:title>The V86M mutation in HIV-1 capsid confers resistance to TRIM5a by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c1e403db9444767cb4a0ba81084e764"><gtr:id>4c1e403db9444767cb4a0ba81084e764</gtr:id><gtr:otherNames>Veillette M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>pm_14669_29_23448277</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA2BDAB0-36FC-433E-A76E-CF5B807BBA66</gtr:id><gtr:title>Cellular self-defense: how cell-autonomous immunity protects against pathogens.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d831d764597269adc1d1578ce82b3c55"><gtr:id>d831d764597269adc1d1578ce82b3c55</gtr:id><gtr:otherNames>Randow F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5460a1507528f2.46735822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D19CC5EA-AA22-46D0-BF19-1213CEE55220</gtr:id><gtr:title>Activation of human ?d T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/180a3baa4fd8918b9d49365fa2a8e310"><gtr:id>180a3baa4fd8918b9d49365fa2a8e310</gtr:id><gtr:otherNames>Rhodes DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56cf148d101be7.10096641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>617FA9C0-A5B5-446A-83D0-4B7CD207A788</gtr:id><gtr:title>Potent lentiviral restriction by a synthetic feline TRIM5 cyclophilin A fusion.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f25e8a22839c8eaf9492900e3ab52a36"><gtr:id>f25e8a22839c8eaf9492900e3ab52a36</gtr:id><gtr:otherNames>Dietrich I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>AVYCnd3oQ2n</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF1A616D-EC18-485D-A152-B1C65C5E845B</gtr:id><gtr:title>HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d09dc58a9541cee561e377d010fb9896"><gtr:id>d09dc58a9541cee561e377d010fb9896</gtr:id><gtr:otherNames>Jacques DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58c922ad727746.04315640</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24BBAC6A-DBDD-4569-8CC7-866D4D5421A4</gtr:id><gtr:title>Diverse HIV viruses are targeted by a conformationally dynamic antiviral.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6994fc2e6e840b1c3dc3b989e831439"><gtr:id>d6994fc2e6e840b1c3dc3b989e831439</gtr:id><gtr:otherNames>Caines ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_14669_29_22407016</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EEC7B03-1E56-4C7A-AB42-E309D0BB5EA2</gtr:id><gtr:title>Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4163edd090b7f7934101c6c7f3ffd2b9"><gtr:id>4163edd090b7f7934101c6c7f3ffd2b9</gtr:id><gtr:otherNames>Fletcher AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56cf160213a488.03007000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDEF89AE-A302-4D33-B547-E51FE75AA49C</gtr:id><gtr:title>Intracellular antibody immunity and the cytosolic Fc receptor TRIM21.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/413eff2f4a5d4faf73a5ac9ea92f6a17"><gtr:id>413eff2f4a5d4faf73a5ac9ea92f6a17</gtr:id><gtr:otherNames>James LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0070-217X</gtr:issn><gtr:outcomeId>5460a152e85973.11646578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33AF3726-3187-4077-AA2C-79D893E071F6</gtr:id><gtr:title>TRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization Activity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed932aa1910feed9372b3da176beb48"><gtr:id>eed932aa1910feed9372b3da176beb48</gtr:id><gtr:otherNames>Foss S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5a3249cd638d15.82244229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08875CB1-7904-44C0-9520-2B6FC475300B</gtr:id><gtr:title>TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4df9e7f0f683b2ba7894330ebcd94ea3"><gtr:id>4df9e7f0f683b2ba7894330ebcd94ea3</gtr:id><gtr:otherNames>Keeble AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>63AE61E00B2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19B761DA-6B18-4665-AC57-B9C16EF61F15</gtr:id><gtr:title>Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5127c337c4d35c97966a996e685b8462"><gtr:id>5127c337c4d35c97966a996e685b8462</gtr:id><gtr:otherNames>McEwan WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>pm_14669_29_23455675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C3586C5-DDA4-4603-9A96-913C82EAC822</gtr:id><gtr:title>Intracellular antibody receptor TRIM21 prevents fatal viral infection.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b19524879648de323234546b049deb32"><gtr:id>b19524879648de323234546b049deb32</gtr:id><gtr:otherNames>Vaysburd M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14669_29_23840060</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F4CDB44-240E-4841-B912-175EC5F4183E</gtr:id><gtr:title>Intracellular antibody immunity.</gtr:title><gtr:parentPublicationTitle>Journal of clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e12615f8d2a81b6cd87d0ed97813bb3a"><gtr:id>e12615f8d2a81b6cd87d0ed97813bb3a</gtr:id><gtr:otherNames>Watkinson RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0271-9142</gtr:issn><gtr:outcomeId>5460a152776723.54861359</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED99ACE2-9108-4AD8-B825-CA0915A76931</gtr:id><gtr:title>Antibody-antigen kinetics constrain intracellular humoral immunity.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfd5f1a4483572fbbc7c51ffec277749"><gtr:id>bfd5f1a4483572fbbc7c51ffec277749</gtr:id><gtr:otherNames>Bottermann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58b98638131339.74787980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F81E7ADE-3363-4AE1-835E-0C3078272267</gtr:id><gtr:title>Intracellular immunity: finding the enemy within--how cells recognize and respond to intracellular pathogens.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a7a2ddb8b458ba0263e2d77aa07dd62"><gtr:id>8a7a2ddb8b458ba0263e2d77aa07dd62</gtr:id><gtr:otherNames>Tam JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>5460a1529c3719.26275695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8280573C-0D67-4F06-8663-07BC5D9835E4</gtr:id><gtr:title>Intracellular antibody-mediated immunity and the role of TRIM21.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5127c337c4d35c97966a996e685b8462"><gtr:id>5127c337c4d35c97966a996e685b8462</gtr:id><gtr:otherNames>McEwan WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>RGVi3MQAc9F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>845908F5-94AF-48CC-943E-44F8393C8DC4</gtr:id><gtr:title>HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ede923f969c5ec692b719203d38f9dc6"><gtr:id>ede923f969c5ec692b719203d38f9dc6</gtr:id><gtr:otherNames>Ocwieja KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>bTvAvfqVGyv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60B704B1-DA48-4857-B6F1-1225A13F243A</gtr:id><gtr:title>A large-scale conformational change couples membrane recruitment to cargo binding in the AP2 clathrin adaptor complex.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d76370cf4cebeed647417eb5323988e8"><gtr:id>d76370cf4cebeed647417eb5323988e8</gtr:id><gtr:otherNames>Jackson LP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>CV1JkfA6tgG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42752546-2BBE-4EF9-8E22-56C69A5E12CE</gtr:id><gtr:title>Antibody- and TRIM21-dependent intracellular restriction of Salmonella enterica.</gtr:title><gtr:parentPublicationTitle>Pathogens and disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6559f47346081699eb716b6168f63a02"><gtr:id>6559f47346081699eb716b6168f63a02</gtr:id><gtr:otherNames>Rakebrandt N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2049-632X</gtr:issn><gtr:outcomeId>5460a152c2d9e2.54028192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32210070-A577-47E2-890C-37FECDAF33AD</gtr:id><gtr:title>Structural and Mechanistic Insights into the Regulation of the Fundamental Rho Regulator RhoGDIa by Lysine Acetylation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c030c55f8abca45f13add23fb49f4cc"><gtr:id>0c030c55f8abca45f13add23fb49f4cc</gtr:id><gtr:otherNames>Kuhlmann N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56cf160266e662.44278263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA631649-C7FB-4D16-8325-41A1C921806A</gtr:id><gtr:title>Coordinated Neutralization and Immune Activation by the Cytosolic Antibody Receptor TRIM21.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4163edd090b7f7934101c6c7f3ffd2b9"><gtr:id>4163edd090b7f7934101c6c7f3ffd2b9</gtr:id><gtr:otherNames>Fletcher AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>58b9866d4b9908.17069238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43401E32-703C-473A-9A82-0EE322563459</gtr:id><gtr:title>TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed932aa1910feed9372b3da176beb48"><gtr:id>eed932aa1910feed9372b3da176beb48</gtr:id><gtr:otherNames>Foss S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>56cf1603044e94.11937876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>840DB598-8055-4BCB-8F37-B11D524F8C33</gtr:id><gtr:title>AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82bbc881c50143984a95d9c71e3a4ef5"><gtr:id>82bbc881c50143984a95d9c71e3a4ef5</gtr:id><gtr:otherNames>Hauler F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14669_29_23091005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8D95AE8-B679-4647-BEB8-3AE86F5F0D89</gtr:id><gtr:title>Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21).</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c71af6e6a5f6449faafda0c5b494a1f3"><gtr:id>c71af6e6a5f6449faafda0c5b494a1f3</gtr:id><gtr:otherNames>Mallery DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>k9iYCh7UcTN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A3154AD-8C7B-4824-9293-2E0D0360FA13</gtr:id><gtr:title>HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c660668f7b12ef3922555af6a0e45cc5"><gtr:id>c660668f7b12ef3922555af6a0e45cc5</gtr:id><gtr:otherNames>Bichel K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>5460a15224d925.13028026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27EA93E2-7C44-4FE2-9BE1-B8A482184C03</gtr:id><gtr:title>Intracellular sensing of complement C3 activates cell autonomous immunity.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a7a2ddb8b458ba0263e2d77aa07dd62"><gtr:id>8a7a2ddb8b458ba0263e2d77aa07dd62</gtr:id><gtr:otherNames>Tam JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5460a1aaeb6482.82359625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7C4A7B3-8578-420B-ABF2-3C44606E831C</gtr:id><gtr:title>Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/413eff2f4a5d4faf73a5ac9ea92f6a17"><gtr:id>413eff2f4a5d4faf73a5ac9ea92f6a17</gtr:id><gtr:otherNames>James LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>2D1F287395E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4C82B47-1922-44F1-A134-12CBE9573F8B</gtr:id><gtr:title>A Method for the Acute and Rapid Degradation of Endogenous Proteins.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a98e1a7161f1d469e4f5a796dc3f9e9a"><gtr:id>a98e1a7161f1d469e4f5a796dc3f9e9a</gtr:id><gtr:otherNames>Clift D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>5a2fd7e407fd67.48031301</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105181010</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>